147 related articles for article (PubMed ID: 38773921)
1. [Treatment of Graves' disease is moving towards precision medicine].
Filipsson Nyström H; Dahlberg J; Lundberg C; Wallin G; Bergman V; Lindo A
Lakartidningen; 2024 May; 121():. PubMed ID: 38773921
[TBL] [Abstract][Full Text] [Related]
2. The Long-Term Outcome of Treatment for Graves' Hyperthyroidism.
Sjölin G; Holmberg M; Törring O; Byström K; Khamisi S; de Laval D; Abraham-Nordling M; Calissendorff J; Lantz M; Hallengren B; Filipsson Nyström H; Wallin G
Thyroid; 2019 Nov; 29(11):1545-1557. PubMed ID: 31482765
[No Abstract] [Full Text] [Related]
3. Pregnancy after definitive treatment for Graves' disease--does treatment choice influence outcome?
Elston MS; Tu'akoi K; Meyer-Rochow GY; Tamatea JA; Conaglen JV
Aust N Z J Obstet Gynaecol; 2014 Aug; 54(4):317-21. PubMed ID: 24576228
[TBL] [Abstract][Full Text] [Related]
4. [Autoimmune diseases of the thyroid gland].
Allelein S; Feldkamp J; Schott M
Internist (Berl); 2017 Jan; 58(1):47-58. PubMed ID: 28074218
[TBL] [Abstract][Full Text] [Related]
5. Relapse of Graves' disease 23 years after treatment with radioactive iodine (131I).
Hegele RA; Volpé R
J Clin Lab Immunol; 1985 Oct; 18(2):103-5. PubMed ID: 3841162
[TBL] [Abstract][Full Text] [Related]
6. Pediatric Graves' disease: decisions regarding therapy.
Okawa ER; Grant FD; Smith JR
Curr Opin Pediatr; 2015 Aug; 27(4):442-7. PubMed ID: 26087421
[TBL] [Abstract][Full Text] [Related]
7. Graves' Disease: Can It Be Cured?
Wiersinga WM
Endocrinol Metab (Seoul); 2019 Mar; 34(1):29-38. PubMed ID: 30912336
[TBL] [Abstract][Full Text] [Related]
8. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group.
Tallstedt L; Lundell G; Tørring O; Wallin G; Ljunggren JG; Blomgren H; Taube A
N Engl J Med; 1992 Jun; 326(26):1733-8. PubMed ID: 1489388
[TBL] [Abstract][Full Text] [Related]
9. Total thyroidectomy for Graves' disease.
Razack MS; Lore JM; Lippes HA; Schaefer DP; Rassael H
Head Neck; 1997 Aug; 19(5):378-83. PubMed ID: 9243264
[TBL] [Abstract][Full Text] [Related]
10. Radioactive iodine therapy for pediatric Graves' disease: a single-center experience over a 10-year period.
Kaplowitz PB; Jiang J; Vaidyanathan P
J Pediatr Endocrinol Metab; 2020 Mar; 33(3):383-389. PubMed ID: 31603857
[TBL] [Abstract][Full Text] [Related]
11. Impaired Na+,K+ATPase activity in red blood cells in euthyroid women treated with levothyroxine after total thyroidectomy for Graves' disease.
De Riva C; Vircici F
Metabolism; 1998 Oct; 47(10):1194-8. PubMed ID: 9781620
[TBL] [Abstract][Full Text] [Related]
12. Graves' Disease Pharmacotherapy in Women of Reproductive Age.
Prunty JJ; Heise CD; Chaffin DG
Pharmacotherapy; 2016 Jan; 36(1):64-83. PubMed ID: 26799350
[TBL] [Abstract][Full Text] [Related]
13. [Radioiodine versus surgery in the treatment of Graves' hyperthyroidism].
Jukić T; Stanicić J; Petric V; Kusić Z
Lijec Vjesn; 2010; 132(11-12):355-60. PubMed ID: 21294325
[TBL] [Abstract][Full Text] [Related]
14. Effect on exophthalmos of various methods of treatment of Graves' disease.
Gwinup G; Elias AN; Ascher MS
JAMA; 1982 Apr; 247(15):2135-8. PubMed ID: 6895919
[TBL] [Abstract][Full Text] [Related]
15. Graves' disease in children.
Léger J; Oliver I; Rodrigue D; Lambert AS; Coutant R
Ann Endocrinol (Paris); 2018 Dec; 79(6):647-655. PubMed ID: 30180972
[TBL] [Abstract][Full Text] [Related]
16. Graves' disease in adults Antithyroid drugs, radioactive iodine, or sometimes thyroidectomy.
Prescrire Int; 2017 Mar; 26(180):72-77. PubMed ID: 30730622
[TBL] [Abstract][Full Text] [Related]
17. Variation in the use of definitive treatment options in the management of Graves' disease: a UK clinician survey.
Hookham J; Collins EE; Allahabadia A; Balasubramanian SP
Postgrad Med J; 2017 Apr; 93(1098):198-204. PubMed ID: 27531964
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology, management and outcomes of Graves' disease-real life data.
Hussain YS; Hookham JC; Allahabadia A; Balasubramanian SP
Endocrine; 2017 Jun; 56(3):568-578. PubMed ID: 28478488
[TBL] [Abstract][Full Text] [Related]
19. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists.
Bahn Chair RS; Burch HB; Cooper DS; Garber JR; Greenlee MC; Klein I; Laurberg P; McDougall IR; Montori VM; Rivkees SA; Ross DS; Sosa JA; Stan MN; ;
Thyroid; 2011 Jun; 21(6):593-646. PubMed ID: 21510801
[TBL] [Abstract][Full Text] [Related]
20. Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort study.
Okosieme OE; Taylor PN; Evans C; Thayer D; Chai A; Khan I; Draman MS; Tennant B; Geen J; Sayers A; French R; Lazarus JH; Premawardhana LD; Dayan CM
Lancet Diabetes Endocrinol; 2019 Apr; 7(4):278-287. PubMed ID: 30827829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]